Skip to main content
. 2017 Feb 6;6(2):e1171447. doi: 10.1080/2162402X.2016.1171447

Table 3.

Clinical relevance of HLA class II expression.

Tumor type HLA class II level Prognosis Citation
CRC High Favorable 72-74,80
Larynx squamous cell carcinoma High Favorable 71
Oropharyngeal squamous arcinoma High Favorable 40
Melanoma High Poor 76, 77
Cervical cancer High Poor 75
Osteosarcoma High Controverse 78, 79
Pediatric adrenocortical tumors Low Poor 63